Experimental drug lowers lipoprotein(a), a suspect in heart attacks

A new drug lower blood levels of lipoprotein(a) or Lp(a), a fatty particle linked to a heightened risk of heart attack and narrowing of the aortic valve. The drug, given by injection, works by silencing the gene that causes liver cells to make Lp(a).